Results 191 to 200 of about 40,069 (236)
Some of the next articles are maybe not open access.
PCR and culture for diagnosis of Acanthamoeba keratitis
British Journal of Ophthalmology, 2020Background/Aims Acanthamoeba keratitis (AK) is a rare but sight-threatening infection. Molecular diagnosis of corneal scraping has improved the diagnosis of AK. Different molecular targets and conditions have been used in diagnosis thus far.
H. Yera +9 more
semanticscholar +1 more source
Bulletin de la Societe belge d'ophtalmologie, 1993
During the last year we came across three cases of Acanthamoeba keratitis. They were all contact lens wearers. The diagnosis of Acanthamoeba keratitis was established by the history, clinical picture and the culture of corneal and conjunctival swabs. The patients were treated with metronidazole (Flagyl) 0.5% eyedrops, propamidine isethionate (Brolene ...
E, Draulans, P C, Maudgal
openaire +3 more sources
During the last year we came across three cases of Acanthamoeba keratitis. They were all contact lens wearers. The diagnosis of Acanthamoeba keratitis was established by the history, clinical picture and the culture of corneal and conjunctival swabs. The patients were treated with metronidazole (Flagyl) 0.5% eyedrops, propamidine isethionate (Brolene ...
E, Draulans, P C, Maudgal
openaire +3 more sources
Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
Cornea, 2020PURPOSE Voriconazole was shown to inhibit ergosterol synthesis in various acanthamoeba species. The purpose of this study was to evaluate the clinical outcome of treatment with supplemental topical voriconazole in patients with acanthamoeba keratitis (AK)
Aytan Musayeva +5 more
semanticscholar +1 more source
Topical corticosteroids in Acanthamoeba keratitis: Friend or foe?
European Journal of Ophthalmology, 2020Background/Aims: To analyse the effect of topical corticosteroids before start of anti-amoebic therapy (AAT) in Acanthamoeba keratitis (AK) on final visual outcome and to identify factors that affect the outcome.
Karlijn A Wouters +4 more
semanticscholar +1 more source
Cornea, 2020
PURPOSE To compare the clinical profiles and outcomes of patients with Acanthamoeba keratitis with or without mixed bacterial infection. METHODS A retrospective analysis of microbiologically confirmed AK cases presenting to a tertiary care center over ...
Arshi Singh +3 more
semanticscholar +1 more source
PURPOSE To compare the clinical profiles and outcomes of patients with Acanthamoeba keratitis with or without mixed bacterial infection. METHODS A retrospective analysis of microbiologically confirmed AK cases presenting to a tertiary care center over ...
Arshi Singh +3 more
semanticscholar +1 more source
Systemic Miltefosine as an Adjunct Treatment of Progressive Acanthamoeba Keratitis
Ocular immunology and inflammation, 2020Purpose: To report our experience with oral miltefosine (MLT) as an adjunct treatment for progressive Acanthamoeba keratitis (AK). Methods: Retrospective case series of all patients who underwent treatment with oral MLT for AK at Bascom Palmer Eye ...
Andrea Naranjo +4 more
semanticscholar +1 more source
Rose Bengal-Mediated Photodynamic Antimicrobial Treatment of Acanthamoeba Keratitis
Current Eye Research, 2020Purpose: To evaluate the in vivo efficacy of rose bengal (RB)-mediated photodynamic antimicrobial therapy (PDAT) for treatment of Acanthamoeba castellanii keratitis (AK).
H. T. Atalay +9 more
semanticscholar +1 more source
Efficacy of Photodynamic Anti‐Microbial Chemotherapy for Acanthamoeba Keratitis In Vivo
Lasers in Surgery and Medicine, 2020Acanthamoeba keratitis is a sight‐threatening infectious disease that is difficult to treat. The aim of this study was to evaluate TONS504 (cationic chlorin derivative photosensitizer)‐mediated photodynamic antimicrobial chemotherapy (PACT) in vivo as a ...
Yunialthy Dwia Pertiwi +6 more
semanticscholar +1 more source